KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Pension (2017 - 2025)

Novartis Ag (NVS) has disclosed Pension for 9 consecutive years, with $1.6 billion as the latest value for Q4 2025.

  • Quarterly Pension rose 4.07% to $1.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 billion through Dec 2025, up 4.07% year-over-year, with the annual reading at $1.6 billion for FY2025, 4.07% up from the prior year.
  • Pension hit $1.6 billion in Q4 2025 for Novartis Ag, up from $1.6 billion in the prior quarter.
  • In the past five years, Pension ranged from a high of $2.6 billion in Q4 2021 to a low of $1.6 billion in Q4 2024.
  • Historically, Pension has averaged $1.9 billion across 5 years, with a median of $1.7 billion in 2022.
  • Biggest five-year swings in Pension: plummeted 34.73% in 2022 and later rose 5.34% in 2023.
  • Year by year, Pension stood at $2.6 billion in 2021, then tumbled by 34.73% to $1.7 billion in 2022, then increased by 5.34% to $1.8 billion in 2023, then fell by 13.44% to $1.6 billion in 2024, then grew by 4.07% to $1.6 billion in 2025.
  • Business Quant data shows Pension for NVS at $1.6 billion in Q4 2025, $1.6 billion in Q4 2024, and $1.8 billion in Q4 2023.